Bulletin
Investor Alert

ADC Therapeutics S.A.

NYS: ADCT

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jun 30, 2022, 4:06 p.m.

/zigman2/quotes/214411413/composite

$

7.71

Change

-0.24 -3.02%

Volume

Volume 211

Quotes are delayed by 20 min

/zigman2/quotes/214411413/composite

Previous close

$ 7.79

$ 7.95

Change

+0.16 +2.05%

Day low

Day high

$7.39

$7.95

Open

52 week low

52 week high

$5.52

$32.00

Open
Sorry, there are no insider transactions for this symbol.

Transaction Summary

Total insider purchases and sales reported to the SEC

Data not available.

Officers and Executives

Mr. Ron Squarer
Chairman
Mr. Ameet Mallik
President & Chief Executive Officer
Ms. Jennifer Creel
Chief Financial Officer
Dr. Joseph S. Camardo
Chief Medical Officer & Senior Vice President
Dr. Patrick van Berkel
Senior Vice President-Research & Development
Dr. Peter Greaney
Head-Corporate Development
Ms. Susan Romanus
Chief Compliance Officer
Ms. Jennifer L. Herron
Chief Commercial Officer & Senior Vice President
Mr. David Gilman
Chief Business & Strategy Officer
Mr. Richard A. Onyett
Vice President-Business Development
Mr. Michael Forer
Vice Chairman, Executive VP & General Counsel
Dr. Christopher John Martin
Non-Executive Director
Mr. Robert A. Schmidt
Chief Accounting Officer, VP & Controller
Ms. Amanda Hamilton
Head-Investor Relations
Ms. Kimberly Pope
Chief Human Resources Officer & Senior VP
Dr. Tyrell J. Rivers
Independent Non-Executive Director
Dr. Victor Sandor
Independent Non-Executive Director
Ms. Viviane Monges
Independent Non-Executive Director
Dr. Peter Bartley Corr
Independent Non-Executive Director
Mr. Stephen Ralfe Evans-Freke
Independent Non-Executive Director
Mr. Jacques Theurillat
Independent Non-Executive Director
Mr. Thomas Pfisterer
Independent Non-Executive Director
Dr. Thomas M. Rinderknecht
Independent Non-Executive Director
Dr. Peter Hug
Independent Non-Executive Director
Link to MarketWatch's Slice.